As of 3 Nov 2026, nPhase has raised $30M across 1 verified round on record; latest: $30 million Series D led by Viking Global Investors, announced 2 Nov 2026.
A clinical research technology company that connects clinical trial and real-world data into a single foundation for clinical decision-making
nphase.aiAtlantic Beach, Fla.AIFounded 2016
22 sources · checked 2 times, last 1d ago
The article is dated Nov. 3, but the embedded company-release dateline is Nov. 2, which fixes the announcement date. Atlantic Beach is a dateline, not a stated headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series D | $30M | 2026-11-02 | Viking Global Investors | 20 outlets. #18 in Trending |
22 sources · checked 2 times, last 1d ago [ VERIFIED ] read against 1 of 22 sources The article is dated Nov. 3, but the embedded company-release dateline is Nov. 2, which fixes the announcement date. Atlantic Beach is a dateline, not a stated headquarters. | ||||
nPhase, Inc. builds clinical-research technology that connects clinical-trial and real-world data into a single foundation for clinical decision-making, with nPhase.ai for pharmaceutical sponsors and CROs and REDCap Cloud for smaller sponsors, nonprofit and academic research, MedTech studies, and real-world-data programs.
Checked against 10 sources yesterday
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Series B Convertible Preferred Stock | $1.6MM | 2017-07-07 | not stated | |